Hesketh PJ et al (2020) Antiemetics: ASCO guideline update. J Clin Oncol 38(24):2782–2797

Article  CAS  PubMed  Google Scholar 

Hwangbo Y, Lee EK (2017) Acute hyperglycemia associated with anti-cancer medication. Endocrinol Metab (Seoul) 32(1):23–29

Article  CAS  PubMed  Google Scholar 

Ahn HR et al (2020) Hyperglycemia during adjuvant chemotherapy as a prognostic factor in breast cancer patients without diabetes. J Breast Cancer 23(4):398–409

Article  PubMed  PubMed Central  Google Scholar 

Phillips AL, Reeves DJ, Storey S (2023) Impact of diabetes (type 2) and glycemic control on health-related outcomes of patients receiving chemotherapy for non-metastatic breast cancer: a retrospective analysis. Support Care Cancer 31(2):114

Article  PubMed  Google Scholar 

Brunello A, Kapoor R, Extermann M (2011) Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol 34(3):292–296

Article  CAS  PubMed  Google Scholar 

Kristjanson M et al (2023) Steroid-induced hyperglycemia and Its effect on outcomes of R-CHOP chemotherapy for diffuse large B-Cell lymphoma. Curr Oncol 30(12):10142–10151

Article  PubMed  PubMed Central  Google Scholar 

Hershey DS, Hession S (2017) Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis. Asia Pac J Oncol Nurs 4(3):224–232

Article  PubMed  PubMed Central  Google Scholar 

Hershman DL et al (2016) Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials. J Clin Oncol 34(25):3014–3022

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandil I, Keely E (2022) Glucocorticoid-induced hyperglycemia in oncologic outpatients: a narrative review using the quadruple aim framework. Can J Diabetes 46(7):730–739

Article  PubMed  Google Scholar 

Legris P et al (2023) Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring. Acta Diabetol 60(4):545–552

Article  CAS  PubMed  Google Scholar 

FreeStyle Libre Pro Product. [cited 2024 November 1]; Available from: https://www.myfreestyle.com.

6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024. Diabetes Care, 2024. 47(Suppl 1): p. S111-s125.

Shohat N et al (2019) 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study. Bone Joint J 101-b(7_Supple_C):3–9

Article  CAS  PubMed  Google Scholar 

Malmström H et al (2014) Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies–cross-sectional and longitudinal experience from the AMORIS cohort. PLoS ONE 9(10):e111463

Article  PubMed  PubMed Central  Google Scholar 

Postma TJ et al (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135–1139

Article  CAS  PubMed  Google Scholar 

PROMIS Scoring Guideline: Overview. [cited 2024 November 30]; Available from: https://www.assessmentcenter.net.

Mendoza TR et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196

Article  CAS  PubMed  Google Scholar 

Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20(1):17–25

Article  CAS  PubMed  Google Scholar 

Shah VN et al (2019) Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab 104(10):4356–4364

Article  PubMed  PubMed Central  Google Scholar 

Soysal DE et al (2012) Evaluation of transient hyperglycemia in non-diabetic patients with febrile neutropenia. Eur J Intern Med 23(4):342–346

Article  PubMed  Google Scholar 

Sonabend RY et al (2008) Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer 51(3):387–392

Article  PubMed  Google Scholar 

2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care, 2024. 47(Suppl 1): p. S20-s42.

Yuen KC, McDaniel PA, Riddle MC (2012) Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action. Clin Endocrinol (Oxf) 77(2):224–232

Article  CAS  PubMed  Google Scholar 

Kleinhans M et al (2024) Continuous glucose monitoring of steroid-induced hyperglycemia in patients with dermatologic diseases. J Diabetes Sci Technol 18(4):904–910

Article  CAS  PubMed  Google Scholar 

Horby P et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384(8):693–704

Article  CAS  PubMed  Google Scholar 

Brooks D et al (2022) Glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in COVID-19 infection: a systematic review. Endocr Pract 28(11):1166–1177

Article  PubMed  PubMed Central  Google Scholar 

Cho JH, Suh S (2024) Glucocorticoid-induced hyperglycemia: a neglected problem. Endocrinol Metab (Seoul) 39(2):222–238

Article  CAS  PubMed  Google Scholar 

Liu XX et al (2014) Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 65(4):324–332

Article  CAS  PubMed  Google Scholar 

Healy SJ et al (2017) Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies. Endocrine 56(1):90–97

Article  CAS  PubMed  Google Scholar 

Saito Y et al (2022) Influence of dose reduction of prophylactic dexamethasone on chemotherapy-induced nausea and anorexia in patients under 55 years old treated with anthracycline-containing regimens. Anticancer Res 42(7):3753–3758

Article  CAS  PubMed  Google Scholar 

Saito Y et al (2021) Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment. Sci Rep 11(1):23298

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordon C et al (2023) Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c. Diabet Epidemiol Manag 10:100123

Article  PubMed  Google Scholar 

Gu J et al (2021) Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Support Care Cancer 29(12):7461–7469

Article  PubMed  PubMed Central  Google Scholar 

Klahr MP et al (2024) Association between hyperglycemia and the development of chemotherapy-induced peripheral neuropathy among patients with breast cancer. J Clin Oncol 42(16_suppl):12125–12125

Article  Google Scholar 

Qiu J, Zheng Q, Meng X (2021) Hyperglycemia and chemoresistance in breast cancer: from cellular mechanisms to treatment response. Front Oncol 11:628359

Article  CAS  PubMed  PubMed Central